Abstract:The global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated scientists to satisfy an urgent need for a rapid and accurate detection of pathogens. Traditionally, the culture-based technique is considered as the gold standard for pathogen detection, yet it has a long turnaround time due to the overnight culturing and pathogen isolation. Alternatively, nucleic acid amplification tests provide a relatively shorter turnaround time to identify whether pathogens exist in individuals with high sensitivity and high specificity. In most cases, nucleic acid amplification tests undergo three steps: sample preparation, nucleic acid amplification, and signal transduction. Despite the explosive advancement in nucleic acid amplification and signal transduction technologies, the complex and labor-intensive sample preparation steps remain a bottleneck to create a transformative integrated point-of-care (POC) molecular diagnostic device. Researchers have attempted to simplify and integrate the sample preparations for nucleic acid-based molecular diagnostic devices with innovative progress in integration strategies, engineered materials, reagent storages, and fluid actuation. Therefore, understanding the know-how and obtaining truthful knowledge of existing integrated POC molecular diagnostic devices comprising sample preparations, nucleic acid amplification, and signal transduction can generate innovative solutions to achieve personalized precision medicine and improve global health.In this Account, we discuss the challenges of automated sample preparation solutions integrated with nucleic acid amplification and signal transduction for rapid and precise home diagnostics. Blood, nasal swab, saliva, urine, and stool are emphasized as the most commonly used clinical samples for integrated POC molecular diagnostics of infectious diseases. Even though these five types of samples possess relatively correlated biomarkers due to the human body's circulatory system, each shows unique properties and exclusive advantages for molecular diagnostics in specific situations, which are included in this Account. We examine different integrated POC devices for sample preparation, which includes pathogen isolation and enrichment from the crude sample and nucleic acid purification from isolated pathogens. We present the promising on-chip integration approaches for nucleic acid amplification. We also investigate the on-chip integration methods for reagent storage, which is crucial to simplify the manual operation for end-users. Finally, we present several integrated POC molecular diagnostic devices for infectious diseases. The integrated sample preparation and nucleic acid amplification approach reviewed here can potentially impact the next generation of POC molecular home diagnostic chips, which will significantly impact public health, emergency medicine, and global biosecurity.

Rational clinical use of near-patient analytical systems for molecular detection of infectious agents

Development of Integrated Systems for On-Site Infection Detection

[Recent Advances in Molecular Point of Care Tests]

Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line?

The point-of-care-testing of nucleic acids by chip, cartridge and paper sensors

Point-Of-Care or Point-Of-Need Diagnostic Tests: Time to Change Outbreak Investigation and Pathogen Detection

Lateral flow–based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use

Fully Integrated Microfluidic Devices for Qualitative, Quantitative and Digital Nucleic Acids Testing at Point of Care

Integrated Point-of-Care Molecular Diagnostic Devices for Infectious Diseases

Emerging ultrafast nucleic acid amplification technologies for next-generation molecular diagnostics

Rapid Molecular Diagnostics of Pneumonia Caused by Gram-Negative Bacteria: A Clinician's Review

Molecular Point‐of‐Care Assay Development: Design and Considerations

Ensuring accuracy in the development and application of nucleic acid amplification tests (NAATs) for infectious disease

Rapid Molecular Testing for UTIs: A Diagnostic Stewardship Perspective

Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid

Advances and Challenges of Fully Integrated Paper-Based Point-of-care Nucleic Acid Testing

Portable Paper-Based Nucleic Acid Enrichment for Field Testing

Point-of-care testing: state-of-the art and perspectives

[Diagnosis by isothermal amplification of nucleic acids. Opportunity for community pharmacies]

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology

Paper-based sample-to-answer molecular diagnostic platform for point-of-care diagnostics